A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Clinical trial NCT05702489 · COMPLETED

Trial details

NCT number: NCT05702489
Sponsor: Nanjing Zenshine Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2022-07-17
Primary completion: 2023-05-26
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.